Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprazan Dual Therapy vs Bismuth Quadruple Therapy for H. pylori
NCT05438550Phase 4Unknown
- Sponsor
- Shandong University
- Start
- Feb 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tegoprazan in Helicobacter pylori infection (2 arms), sponsored by Shandong University. Primary endpoint: Eradication rate. Status: unknown.
02
Drugs
tegoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05438550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05438550.